EMMPRIN Regulates Tissue Remodeling in the Endometrium

EMMPRIN 调节子宫内膜组织重塑

基本信息

  • 批准号:
    7315881
  • 负责人:
  • 金额:
    $ 27.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

Endometriosis is defined as the presence of endometrial glands and stroma at ectopic sites, most commonly on the peritoneum within the pelvic cavity. The incidence of endometriosis is estimated to range from 30- 60% in women with pelvic pain and infertility and the associated health care costs are enormous. Implantation of endometrial fragments at ectopic sites is thought to be regulated by cytokines and growth factors secreted locally by immune cells as well as by the endometrial cells themselves. The infertility that is often associated with endometriosis is due, at least in part, to alterations in gene expression in the eutopic endometrium. These altered patterns of gene expression result in an endometrial environment that is not receptive to the implanting embryo and cannot sustain its development. We have shown that a glycosylated, trans-membrane protein called Extra-Cellular Matrix Metalloproteinase Inducer (EMMPRIN) is expressed in both the human and mouse uterus and regulates production of metalloproteinases by uterine stromal cells. EMMPRIN expression is upregulated in eutopic as well as ectopic endometrium of women and baboons with endometriosis. Using a mouse EMMPRIN knockout model we have shown that in mice lacking EMMPRIN expression, uterine stromal cells experience premature decidualization in response to oil injection and are infertile. Treatment of cultured uterine stromal cells with EMMPRIN inhibits expression of decidualization markers such as alkaline phosphatase-2 and induces expression of several cytokines and chemokines by these cells. Thus it appears that EMMPRIN is a multi-functional regulator of endometrial remodeling. Our specific aims are; #1: To determine how secretion of full-length, soluble EMMPRIN by uterine epithelial cells is regulated and how EMMPRIN regulates production of cytokines, chemokines and angiogenic factors by uterine stromal cells. #2: To determine how EMMPRIN regulates proliferation and decidualization of uterine stromal cells and to clarify the intra-cellular signaling pathway used by EMMPRIN in these cells. #3: To determine the effects of EMMPRIN on epithelial-to-mesenchymal transition of mesothelial cells. The proposed studies will clarify the role of EMMPRIN in invasion of endometrial fragments through the mesothelium leading to establishment of endometriotic lesions. They will also help to explain why aberrant expression of EMMPRIN in eutopic endometrium could result in failure of implantation.
子宫内膜异位症的定义是在异位部位存在子宫内膜腺体和间质,最常见的是 在盆腔的腹膜上子宫内膜异位症的发病率估计在30- 60%的女性患有盆腔疼痛和不孕症,相关的医疗费用也是巨大的。 异位子宫内膜碎片的植入被认为受细胞因子和生长的调节 免疫细胞和子宫内膜细胞自身局部分泌的因子。不孕症是 通常与子宫内膜异位症相关的一种疾病,至少部分是由于在位基因表达的改变, 子宫内膜这些改变的基因表达模式导致子宫内膜环境, 接受植入的胚胎,不能维持其发展。我们已经证明了糖基化, 称为细胞外基质金属蛋白酶诱导因子(EMMPRIN)的跨膜蛋白在大肠杆菌中表达。 人和小鼠子宫,并调节子宫基质细胞的金属蛋白酶的产生。 EMMPRIN表达在患有子宫内膜异位症的妇女和狒狒的在位和异位子宫内膜中上调, 子宫内膜异位症使用小鼠EMMPRIN敲除模型,我们已经表明,在缺乏EMMPRIN的小鼠中, 表达,子宫基质细胞经历对油注射的响应的过早蜕膜化, 不能生育EMMPRIN抑制子宫基质细胞蜕膜化表达 标志物如碱性磷酸酶-2,并通过以下途径诱导几种细胞因子和趋化因子的表达: 这些细胞。因此,EMMPRIN似乎是子宫内膜重塑的多功能调节剂。我们 具体目标是:#1:确定子宫上皮细胞分泌全长可溶性EMMPRIN的方式 以及EMMPRIN如何通过调节细胞因子、趋化因子和血管生成因子的产生 子宫基质细胞#2:确定EMMPRIN如何调节子宫内膜增殖和蜕膜化 间质细胞,并阐明EMMPRIN在这些细胞中使用的细胞内信号通路。 #3:确定EMMPRIN对间皮细胞上皮-间充质转化的影响。 本研究将通过对EMMPRIN在子宫内膜碎片侵袭中的作用的研究来阐明EMMPRIN在子宫内膜碎片侵袭中的作用。 间皮炎,导致建立增生性病变。它们也将有助于解释为什么 EMMPRIN在在位子宫内膜的表达可导致着床失败。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Romana A. Nowak其他文献

Secretion of a gonadotrophin-releasing hormone- (GnRH-)like factor by the rabbit fetal placenta in vitro.
体外兔胎儿胎盘分泌促性腺激素释放激素(GnRH-)样因子。
  • DOI:
    10.1016/0143-4004(87)90054-3
  • 发表时间:
    1987
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Romana A. Nowak;Janice M. Bahr
  • 通讯作者:
    Janice M. Bahr
An interview with Dr Terry M. Nett
特里·M·内特博士访谈
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Romana A. Nowak
  • 通讯作者:
    Romana A. Nowak
Maternal recognition of pregnancy in the rabbit.
母兔妊娠的识别。
The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and <em>α</em>-subunit in vitro
  • DOI:
    10.1016/s0015-0282(16)57912-6
  • 发表时间:
    1995-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Elizabeth A. Stewart;Prachee Jain;Martha D. Penglase;Andrew J. Friedman;Romana A. Nowak
  • 通讯作者:
    Romana A. Nowak

Romana A. Nowak的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Romana A. Nowak', 18)}}的其他基金

The Role of Glial Cells in Chronic Pelvic Pain of Endometriosis
神经胶质细胞在子宫内膜异位症慢性盆腔疼痛中的作用
  • 批准号:
    10251334
  • 财政年份:
    2020
  • 资助金额:
    $ 27.02万
  • 项目类别:
The Role of Glial Cells in Chronic Pelvic Pain of Endometriosis
神经胶质细胞在子宫内膜异位症慢性盆腔疼痛中的作用
  • 批准号:
    10062360
  • 财政年份:
    2020
  • 资助金额:
    $ 27.02万
  • 项目类别:
Project 3: Mechanisms that Regulate Growth of Leiomyoma Smooth Muscle Cells
项目3:调节平滑肌瘤平滑肌细胞生长的机制
  • 批准号:
    8308001
  • 财政年份:
    2011
  • 资助金额:
    $ 27.02万
  • 项目类别:
Project 3: Mechanisms that Regulate Growth of Leiomyoma Smooth Muscle Cells
项目3:调节平滑肌瘤平滑肌细胞生长的机制
  • 批准号:
    8099640
  • 财政年份:
    2010
  • 资助金额:
    $ 27.02万
  • 项目类别:
A novel model of reproductive and metabolic features of polycystic ovary syndrome
多囊卵巢综合征生殖和代谢特征的新模型
  • 批准号:
    7755393
  • 财政年份:
    2009
  • 资助金额:
    $ 27.02万
  • 项目类别:
Project 3: Mechanisms that Regulate Growth of Leiomyoma Smooth Muscle Cells
项目3:调节平滑肌瘤平滑肌细胞生长的机制
  • 批准号:
    7752687
  • 财政年份:
    2009
  • 资助金额:
    $ 27.02万
  • 项目类别:
Reactive Oxygen Species Regulate Smooth Muscle Growth*
活性氧调节平滑肌生长*
  • 批准号:
    6740630
  • 财政年份:
    2003
  • 资助金额:
    $ 27.02万
  • 项目类别:
Reactive Oxygen Species Regulate Smooth Muscle Growth
活性氧调节平滑肌生长
  • 批准号:
    7271158
  • 财政年份:
    2003
  • 资助金额:
    $ 27.02万
  • 项目类别:
Reactive Oxygen Species Regulate Smooth Muscle Growth*
活性氧调节平滑肌生长*
  • 批准号:
    6946886
  • 财政年份:
    2003
  • 资助金额:
    $ 27.02万
  • 项目类别:
Reactive Oxygen Species Regulate Smooth Muscle Growth*
活性氧调节平滑肌生长*
  • 批准号:
    6805747
  • 财政年份:
    2003
  • 资助金额:
    $ 27.02万
  • 项目类别:

相似海外基金

How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
  • 批准号:
    22KJ0818
  • 财政年份:
    2023
  • 资助金额:
    $ 27.02万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10711027
  • 财政年份:
    2021
  • 资助金额:
    $ 27.02万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10297199
  • 财政年份:
    2021
  • 资助金额:
    $ 27.02万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10625314
  • 财政年份:
    2021
  • 资助金额:
    $ 27.02万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10405070
  • 财政年份:
    2021
  • 资助金额:
    $ 27.02万
  • 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
  • 批准号:
    20K06385
  • 财政年份:
    2020
  • 资助金额:
    $ 27.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
  • 批准号:
    17K11866
  • 财政年份:
    2017
  • 资助金额:
    $ 27.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
  • 批准号:
    15K20874
  • 财政年份:
    2015
  • 资助金额:
    $ 27.02万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
  • 批准号:
    15K15523
  • 财政年份:
    2015
  • 资助金额:
    $ 27.02万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
  • 批准号:
    26860367
  • 财政年份:
    2014
  • 资助金额:
    $ 27.02万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了